Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry.
Argyriou AA, Dermitzakis EV, Xiromerisiou G, Rikos D, Rallis D, Soldatos P, Litsardopoulos P, Andreou AP, Vikelis M. Argyriou AA, et al. Among authors: xiromerisiou g. Expert Rev Neurother. 2024 Nov;24(11):1119-1126. doi: 10.1080/14737175.2024.2403576. Epub 2024 Sep 16. Expert Rev Neurother. 2024. PMID: 39279446
Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints.
Vikelis M, Rikos D, Argyriou AA, Papachristou P, Rallis D, Karapanayiotides T, Galanopoulos A, Spingos K, Dimisianos N, Giakoumakis E, Zavridis P, Notas K, Vlachos GS, Soldatos P, Bilias K, Xiromerisiou G, Rudolf J, Dermitzakis EV, Rapoport AM. Vikelis M, et al. Among authors: xiromerisiou g. Expert Rev Neurother. 2024 Aug;24(8):815-826. doi: 10.1080/14737175.2024.2365312. Epub 2024 Jun 13. Expert Rev Neurother. 2024. PMID: 38870024
Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options.
Dermitzakis EV, Argyriou AA, Bilias K, Barmpa E, Liapi S, Rikos D, Xiromerisiou G, Soldatos P, Vikelis M. Dermitzakis EV, et al. Among authors: xiromerisiou g. J Clin Med. 2024 May 8;13(10):2768. doi: 10.3390/jcm13102768. J Clin Med. 2024. PMID: 38792309 Free PMC article.
Paradigm shift in Parkinson's disease: using continuous telemonitoring to improve symptoms control. Results from a 2-years journey.
Konitsiotis S, Alexoudi A, Zikos P, Sidiropoulos C, Tagaris G, Xiromerisiou G, Tsamis K, Kostikis N, Kanellos F, Ntanis A, Kontaxis S, Rigas G. Konitsiotis S, et al. Among authors: xiromerisiou g. Front Neurol. 2024 Jun 6;15:1415970. doi: 10.3389/fneur.2024.1415970. eCollection 2024. Front Neurol. 2024. PMID: 38903169 Free PMC article.
Clinical and genetic characterization of a progressive RBL2-associated neurodevelopmental disorder.
Aughey GN, Cali E, Maroofian R, Zaki MS, Pagnamenta AT, Ali Z, Abdulllah U, Rahman F, Menzies L, Shafique A, Suri M, Roze E, Aguennouz M, Ghizlane Z, Saadi SM, Fatima A, Cheema HA, Anjum MN, Morel G, Robin S, McFarland R, Altunoglu U, Kraus V, Shoukier M, Murphy D, Flemming K, Yttervik H, Rhouda H, Lesca G, Chatron N, Rossi M, Murtaza BN, Ur Rehman M, Lord J, Giacopuzzi E, Hayat A, Siraj M; SYNAPS Study Group; Badv RS, Seo GH, Beetz C, Kayserili H, Krioulie Y, Chung WK, Naz S, Maqbool S, Chandler K, Kershaw C, Wright T, Banka S, Gleeson JG, Taylor JC, Efthymiou S, Baig SM, Severino M, Jepson JEC, Houlden H. Aughey GN, et al. Brain. 2024 Dec 18:awae363. doi: 10.1093/brain/awae363. Online ahead of print. Brain. 2024. PMID: 39692517
131 results